BOUCHERVILLE, QC, March 17, 2025 /CNW/ - The Government of Canada and Delpharm, a worldwide leader in contract manufacturing and development of medicines, cordially invite media representatives to a press conference to announce a major modernization project for Delpharm's facilities in Boucherville.
This $60 million investment by the Canadian government will allow Delpharm to keep the Boucherville site in the country. It will also secure the local supply chain for sterile injectable drugs and significantly increase Delpharm's global competitiveness.
The event will take place on March 18, in the presence of Sherry Romanado, Parliamentary Secretary to the President of the King's Privy Council for Canada and Minister of Emergency Preparedness, Mathieu Grondin, Site Director of Delpharm, and Michel Robidoux, President and General Manager of Sandoz.
DATE: |
March 18, 2025 |
TIME: |
10 a.m. |
LOCATION : |
145 Rue Jules-Léger |
Please confirm your presence by email: [email protected]
SOURCE Delpharm
Information: Justin Meloche, 514-995-9704, [email protected]
Share this article